ClinicalTrials.gov
public full text
Public Domain
Effect of Cladribine Treatment on Microglial Activation in the CNS
To evaluate the effect of cladribine treatment on microglial activation with conventional MRI, QSM-post processing and TSPO-PET imaging in late stage relapsing remitting multiple sclerosis patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of tDCS and Cognitive Rehabilitation on Cognition and Neural Plasticity in MS Patients#1057054
- 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis#850391
- Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA#1185802
- Accelerated rTMS vs. Sham for Stroke Apathy#804071
- Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression#871155
Record · ID 1228344
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive